A detailed history of Valley Brook Capital Group, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Valley Brook Capital Group, Inc. holds 950 shares of BDX stock, worth $212,800. This represents 0.16% of its overall portfolio holdings.

Number of Shares
950
Previous 950 -0.0%
Holding current value
$212,800
Previous $222,000 3.15%
% of portfolio
0.16%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $10,041 - $11,817
46 Added 5.09%
950 $241,000
Q3 2022

Nov 03, 2022

BUY
$51.03 - $264.23 $204 - $1,056
4 Added 0.44%
904 $201,000
Q4 2020

Mar 19, 2021

BUY
$221.92 - $245.94 $199,728 - $221,346
900 New
900 $225,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Valley Brook Capital Group, Inc. Portfolio

Follow Valley Brook Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley Brook Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valley Brook Capital Group, Inc. with notifications on news.